| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/08/2001 | WO2001009591A1 Method for optical excitation of fluorophore marked dna and rna |
| 02/08/2001 | WO2001009587A1 Method and apparatus for determining quality properties of fish |
| 02/08/2001 | WO2001009585A1 Method for determination of the density of a single fibre |
| 02/08/2001 | WO2001009391A1 Sample arrays and high-throughput testing thereof to detect interactions |
| 02/08/2001 | WO2001009390A1 Tenascin-c nucleic acid ligands |
| 02/08/2001 | WO2001009389A2 Methods and apparatus for template capture and normalization for submicroliter reaction |
| 02/08/2001 | WO2001009381A2 Methods of nucleic acid analysis by detecting molecular binding events |
| 02/08/2001 | WO2001009377A1 Method for detecting nucleic acid target sequences involving in vitro transcription from an rna polymerase promoter |
| 02/08/2001 | WO2001009376A1 Method for amplification of nucleic acids |
| 02/08/2001 | WO2001009374A2 Method for characterizing nucleic acid fragments |
| 02/08/2001 | WO2001009373A2 Native cdc25 substrates, compositions and uses related thereto |
| 02/08/2001 | WO2001009370A2 Detection and identification of bacterial strains |
| 02/08/2001 | WO2001009341A2 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase |
| 02/08/2001 | WO2001009340A1 Proteins derived from white spot syndrome virus and uses thereof |
| 02/08/2001 | WO2001009336A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009334A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009332A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 02/08/2001 | WO2001009328A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 02/08/2001 | WO2001009325A2 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 02/08/2001 | WO2001009313A1 G-protein coupled receptor and dna sequences thereof |
| 02/08/2001 | WO2001009292A2 Sentrin-specific human proteases senp1-3 |
| 02/08/2001 | WO2001009289A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
| 02/08/2001 | WO2001009281A1 Internal quality control |
| 02/08/2001 | WO2001009204A2 Controlled-architecture polymers and use thereof as separation media |
| 02/08/2001 | WO2001009192A1 Human monoclonal antibodies to prostate specific membrane antigen |
| 02/08/2001 | WO2001009191A1 Computational design methods for making molecular mimetics |
| 02/08/2001 | WO2001009190A2 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
| 02/08/2001 | WO2001009189A2 Compositions and methods for the treatment of tumors |
| 02/08/2001 | WO2001009188A1 Binding moieties for fibrin |
| 02/08/2001 | WO2001009187A2 Human monoclonal antibodies to her2/neu |
| 02/08/2001 | WO2001009184A1 Human g-protein coupled receptor |
| 02/08/2001 | WO2001009183A2 Polymorphisms in the human mdr-1 gene and applications thereof |
| 02/08/2001 | WO2001009182A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 02/08/2001 | WO2001009180A1 Creating novel biosensors from natural biological receptors |
| 02/08/2001 | WO2001009179A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 02/08/2001 | WO2001009178A2 Human chaperone proteins |
| 02/08/2001 | WO2001009173A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 02/08/2001 | WO2001009159A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 02/08/2001 | WO2001009158A1 Conditional-selex |
| 02/08/2001 | WO2001009157A1 High affinity vascular endothelial growth factor (vegf) receptor nucleic acid ligands and inhibitors |
| 02/08/2001 | WO2001009156A1 HIGH AFFINITY TGFη NUCLEIC ACID LIGANDS AND INHIBITORS |
| 02/08/2001 | WO2001009041A2 System for protection of building water supplies against chemical and biological warfare agents |
| 02/08/2001 | WO2001008802A1 Low volume chemical and biochemical reaction system |
| 02/08/2001 | WO2001008676A1 Assay for d-serine transport antagonist and use for treating psychosis |
| 02/08/2001 | WO2001008635A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | WO2001008634A2 Polynucleotide encoding a human serine protease |
| 02/08/2001 | WO2001008554A1 Metabolic calorimeter employing respiratory gas analysis |
| 02/08/2001 | WO2001008551A2 Luminous glucose monitoring device |
| 02/08/2001 | WO2001008500A1 Method for assessing the quality of animal half-carcasses |
| 02/08/2001 | WO2000075317A3 Compositions and methods for the treatment of tumor |
| 02/08/2001 | WO2000070340A3 Materials and methods relating to disease diagnosis |
| 02/08/2001 | WO2000070079A8 High throughput assay for modulators of nuclear receptors |
| 02/08/2001 | WO2000067785A3 Staphyloccocus aureus antigen-containing whole cell vaccine |
| 02/08/2001 | WO2000066771A3 Diagnostic sequencing by a combination of specific cleavage and mass spectrometry |
| 02/08/2001 | WO2000065083A3 Feminine sanitary disposable article having a blood detection means as sensor |
| 02/08/2001 | WO2000063667A3 Methods for identifying modulators of n-type ion channel inactivation |
| 02/08/2001 | WO2000063426A3 Compound screening methods |
| 02/08/2001 | WO2000063424A3 Method for screening compounds using nematode worms |
| 02/08/2001 | WO2000063230A3 49 human secreted proteins |
| 02/08/2001 | WO2000061756A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 02/08/2001 | WO2000060361A3 Automated analysers |
| 02/08/2001 | WO2000060355A3 Lfa-1 regulatory binding site and uses thereof |
| 02/08/2001 | WO2000057180A3 Use of lna in mass spectrometry |
| 02/08/2001 | WO2000056916A3 Detection of mutations in genes by specific lna primers |
| 02/08/2001 | WO2000034525A8 Toxicity typing using embryoid bodies |
| 02/08/2001 | WO2000026409A8 Amplified array analysis method and system |
| 02/08/2001 | WO2000005580A8 Method of determining the carry-over of an analyte |
| 02/08/2001 | DE19937230A1 Chimäre Proteine Chimeric proteins |
| 02/08/2001 | DE19937219A1 Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Ionenaustauscherchromatographie A process for the purification of the blood clotting factor VII-activating protease, its pro-enzyme or a mixture of both proteins by ion-exchange chromatography |
| 02/08/2001 | DE19937218A1 Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie A process for the purification of the blood clotting factor VII-activating protease, its pro-enzyme or a mixture of both proteins by affinity chromatography |
| 02/08/2001 | DE19937024A1 Verwendung von Acylsulfonamido substituierten Polymethin-Farbstoffen als Fluoreszenz-Farbstoffe und/oder Marker Using acylsulfonamido substituted polymethine dyes as fluorescent dyes and / or markers |
| 02/08/2001 | DE19936693A1 Instrument for the measurement of blood sugar concentrations has a test field with electrodes for the test strip and a circuit for measurement/evaluation of the current strength for display |
| 02/08/2001 | DE19936563A1 Tumorassoziiertes Antigen Tumor-associated antigen |
| 02/08/2001 | DE19936035A1 Lymphocyte proliferation assay kit useful for diagnosis of Alzheimer's disease comprises an anticoagulant, one or more stimulants and an anti-CD69 antibody |
| 02/08/2001 | DE19935772A1 Verfahren zur relativen Quantifizierung der Methylierung von Cytosin Basen in amplifizierten Nukleinsäurefragmenten Method for the relative quantification of methylation of cytosine bases in nucleic acid amplified fragments |
| 02/08/2001 | DE19935749A1 Verfahren zur Chrakterisierung von Nukleinsäurefragmenten Method for Chrakterisierung of nucleic acid fragments |
| 02/08/2001 | DE19935133A1 Vorrichtung zur Untersuchung des Verhaltens von Umweltchemikalien unter natürlichen Bedingungen Apparatus for investigating the behavior of chemicals in the environment under natural conditions |
| 02/08/2001 | DE19934561A1 Inductively-coupled plasma mass spectrometry process for analysis of historic polar ice samples trace elements |
| 02/08/2001 | DE19923461C1 Verfahren und Vorrichtung zur Messung organischer und anorganischer Begleitfrachten in einem flächigen Gut Method and apparatus for measuring organic and inorganic accompanying freight in a planar Good |
| 02/08/2001 | DE10031339A1 Chucked drilling tool locator comprises larger diameter rollers placed in chuck cylinder to bear increasingly on centraly positioned drill tool as chuck speed increases. |
| 02/08/2001 | CA2697207A1 Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 02/08/2001 | CA2388663A1 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 02/08/2001 | CA2387655A1 Sentrin-specific human proteases senp1-3 |
| 02/08/2001 | CA2381958A1 Method for amplification of nucleic acids |
| 02/08/2001 | CA2381437A1 G-protein coupled receptor and dna sequences thereof |
| 02/08/2001 | CA2381004A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 02/08/2001 | CA2380978A1 Method and device for determining the hardness of products such as fruit |
| 02/08/2001 | CA2380837A1 High affinity tgf.beta. nucleic acid ligands and inhibitors |
| 02/08/2001 | CA2380822A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380813A1 Human monoclonal antibodies to her2/neu |
| 02/08/2001 | CA2380803A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380794A1 Methods and apparatus for template capture and normalization for submicroliter reaction |
| 02/08/2001 | CA2380631A1 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 02/08/2001 | CA2380573A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 02/08/2001 | CA2380535A1 High affinity vascular endothelial growth factor (vegf) receptor nucleic acid ligands and inhibitors |
| 02/08/2001 | CA2380519A1 Method for screening molecules for the treatment of huntington disease |
| 02/08/2001 | CA2380515A1 Polypeptides and polynucleotides from moraxella catarrhalis |
| 02/08/2001 | CA2380500A1 Rodent detection |
| 02/08/2001 | CA2380489A1 Modulating binding site on potassium channels used for screening |
| 02/08/2001 | CA2380473A1 Tenascin-c nucleic acid ligands |